Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

During the Trading Day
3.81 -0.01 / -0.26%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.81 0.00 / 0.00%
 
Volume: --

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +267.45% increase from the last price of 3.81.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
--
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.67%
 
 
 
 
 
 
Growthannually 16.18%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account